PA
UTHR icon

Pineridge Advisors’s United Therapeutics UTHR Stock Holding History

Pineridge Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$5.45K Buy
+13
New +$4.37K ﹤0.01% 256

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Pineridge Advisors's UTHR Position: Q3 2025 in Review

Pineridge Advisors opened a new position in United Therapeutics (UTHR) in Q3 2025: 13 shares worth $5.45K. The stake represents ﹤0.01% of the portfolio and ranks #256 among its holdings.

707 funds tracked by Wall St. Rank hold UTHR as of Q3 2025.

  • Pineridge Advisors held 13 shares of United Therapeutics worth $5.45K as of Q3 2025.
  • United Therapeutics was a new Pineridge Advisors position in Q3 2025.
  • United Therapeutics made up ﹤0.01% of Pineridge Advisors's portfolio in Q3 2025, its #256 holding.
  • 707 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2025.

Based on Pineridge Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.